Resources from the same session
Circulating Tumor Cell Count Kinetics as Surrogate Endpoint of Antitumor Activity
Presenter: J. Mateo, ES
Session: Session 3 - Quantitative Liquid-biopsy Biomarkers as Clinical Trials End Point
Resources:
Slides
Webcast
Role of cfDNA in Monitoring Response and Relapse: the Example of Liquid Biopsy Minimal Residual Disease as Clinical Trial Endpoint
Presenter: V. Morris, US
Session: Session 3 - Quantitative Liquid-biopsy Biomarkers as Clinical Trials End Point
Resources:
Slides
Webcast